HeartSciences (HSCSW) Change in Accured Expenses (2021 - 2026)
HeartSciences' (HSCSW) quarterly Change in Accured Expenses came in at $220790.0 in Q2 2026, down 15.51% on a YoY basis from $261319.0 in Q2 2025, and up 166.06% quarter-over-quarter from -$334208.0 in Q4 2025.
Powered by 
Analysis
HeartSciences (HSCSW) Change in Accured Expenses (2021 - 2026) Analysis & Trends
HeartSciences (HSCSW) has reported Change in Accured Expenses for 6 consecutive years, with $220790.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 15.51% year-over-year to $220790.0; the trailing twelve-month figure through Apr 2026 stood at $314619.0 (up 1773.74% YoY), and the FY2026 full-year result was $121479.0, up 623.48% from the prior year.
- Change in Accured Expenses rose to $220790.0 in Q2 2026 per HSCSW's latest filing, from -$334208.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $371484.0 in Q2 2022 and bottomed at -$477475.0 in Q3 2022.
- Historically, Change in Accured Expenses has averaged $21705.2 across 5 years, with a median of $15744.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses tumbled 997.02% in 2022, then jumped 472.92% in 2025.
- Over 5 years, Change in Accured Expenses stood at $247141.0 in 2022, then tumbled by 126.67% to -$65901.0 in 2023, then slumped by 227.11% to -$215566.0 in 2024, then plunged by 55.04% to -$334208.0 in 2025, then surged by 166.06% to $220790.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $220790.0, -$334208.0, and $166718.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.85 Bn | 27.74 Bn | 2.18 Bn | 19.00 Mn |
| 2 | Lantheus Holdings | 6.57 Bn | 5.98 Bn | 241.86 Mn | -1.99 Mn |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.40 Bn | 107.80 Mn | -700,000.00 |
| 5 | Butterfly Network | 1.99 Bn | 1.87 Bn | 23.29 Mn | 5.23 Mn |
| 6 | Ceribell | 924.56 Mn | 795.30 Mn | 25.94 Mn | -148,000.00 |
| 7 | QuidelOrtho | 874.92 Mn | 751.52 Mn | - | -17.90 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 9.50 Mn |
| 9 | Prenetics Global | 340.90 Mn | 281.85 Mn | 30.20 Mn | 10.52 Mn |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - | 220,790.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 220,790.00 |
| Oct 31, 2025 | -334,208.00 |
| Jul 31, 2025 | 166,718.00 |
| Apr 30, 2025 | 261,319.00 |
| Jan 31, 2025 | 15,744.00 |
| Oct 31, 2024 | -215,566.00 |
| Jul 31, 2024 | -44,706.00 |
| Apr 30, 2024 | 82,718.00 |
| Jan 31, 2024 | -103,237.00 |
| Oct 31, 2023 | -65,901.00 |
| Jul 31, 2023 | 27,730.00 |
| Apr 30, 2023 | -37,346.00 |
| Jan 31, 2023 | -42,466.00 |
| Oct 31, 2022 | 247,141.00 |
| Jul 31, 2022 | -477,475.00 |
| Apr 30, 2022 | 371,484.00 |
| Jan 31, 2022 | 296,250.00 |
| Oct 31, 2021 | 144,380.00 |
| Jul 31, 2021 | 53,229.00 |